Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article

Molecular residual disease (MRD), detected by circulating tumor DNA (ctDNA) can be involved in the entire process of solid tumor management, including recurrence prediction, efficacy evaluation, and risk stratification. Currently, the detection technologies are divided into two main categories, as f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qiantong, Chen, Chenbin, Hu, Yuanbo, Zhang, Weiteng, Yang, Xinxin, Qi, Yingxue, Zhu, Chan, Chen, Xiaodong, Shen, Xian, Ji, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653633/
https://www.ncbi.nlm.nih.gov/pubmed/37955635
http://dx.doi.org/10.1080/15384047.2023.2274123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653633/
https://www.ncbi.nlm.nih.gov/pubmed/37955635
http://dx.doi.org/10.1080/15384047.2023.2274123

Ejemplares similares